Gene Solutions delivers unique mitochondrial therapeutic solutions and choices for pharmaceutical and biotechnology companies seeking to enhance their drug pipelines in the field of Central Nervous System diseases. Using our unparalleled mitochondrial genetic, therapeutic and diagnostic expertise – and fortified by our complementary UK and US science teams - we develop and validate leads, binding and cell-based assays, and companion diagnostics for some of the world’s most devastating diseases.